1Zhang PP, Sun JW, Wang XY, et al. Preoperative plasma D-dimer levels predict survival in patients with operable non- small cell lung cancer independently of venous Ihromboembolism [ J ]. European Journal of Surgical Oncology ( EJSO), 2013, 39 (9) : 951-956.
2Gronostaj K, Richter P, Nowak W, et al. Altered plasma fibrin clot properties in patients with digestive tract cancers: liuks with the increased thrombin generation [ J ]. Thrombosis Researeh, 2013, 131(3) : 262-267.
5Targofiski R, Cygafiski P, Kuciel-l,isiska G, et al. Perioperative disorders of coagulation and fibrinolysis in patients subjected to eolorectal cancer resection [ J]. Pol An Med, 2011, 18 ( 1 ) : 52-65.
6Seth R, Tai LH, Falls T, et al. Surgical stress plxmlotes the development of cancer metastases by a coagulation-dependent mechanism involving natural killer cells in a murine model [ J ]. Ann Sarg, 2013, 258(1 ) : 158-168.
7Suh DH, Kim HS, Chung HH, et al. Pre-opcrative systemic inflammatm'y response markers in predicting lymph node metastasis in endometrioid endometrial ademwarcinoma [J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2012, 162(2) : 206-210.
8Tang L, I.iu K, Wang J, et al. High preoperative plasma fibrinogen levels are associated with distant metastases and impaired prognosis after curative resection in patients with coloreetal cancer[J]. J Sm; Oncol, 2010, 102(5) : 428-432.
9Stegner D, Diitting S, Nieswandt B. Mechanistic explanation for platelet contribution to cancer metastasis [ J ]. Thromhosis Research, 2014, 133 : S149-S157.
二级参考文献16
1Grossmann I, de Bock GH, van de Velde C J, et al. Results of a national survey among Dutch surgeons treating patients with coloreetal carcinoma. Current opinion about follow-up, treatment of metastasis,and reasons to revise follow-up praetiee. Coloreetal Dis, 2007,9 : 787 -792.
2Yamanloto M, Maehara Y, Sakaguchi Y,et al. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas. Hepatogastroenterology,2004,51:147-151.
3Goldstein M J, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest, 2005,23 : 338 -351.
4Abir F, Alva S, Longo WE, et al, Thepost-operative surveillanee of Parient with colon cancer and rectal cancer Am J Surg, 2006, 192 : 100-108.
5Grossmann I, de Bock GH, Meershoek-Klein Kranenbarg WM, et al. Carcinoembryonic antigen ( CEA ) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial. Eur J Surg Oncol,2007,33 : 183-187.
6Forrest LM, McMillan DC, McArdle CS, et al. A prospeclive longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small- cell lung cancer. Br J Cancer, 2005, 92:1834 -1836.
7Elahi MM, MeMillan DC, McArdle CS, et al. Scnre based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer, 2004, 48 : 171-173.
8Crumley AB, McMillan DC, McKeroan M, et al. Evaluation ot an inflamnmtion-based prognostic score in patients with inoperable gastrooesophageal cancer. Br J Cancer, 2006,94:637- 641.
9Nielsen HJ, Christensen IJ, Sorensen S, et al. Preoperative plasma plasminogen activator inhibitor type-1 and serum C- reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group,2000, 7:617-623.
10Heys SD, Walker LG, Deehan DJ, et al. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coil Surg Edinb, 1998, 43 : 163-168.
